Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5542 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 37 38 39 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Implandata–Peppermint: investment, 201208 financing round Series A 2nd closing totalling €1.6m Peppermint + EnjoyVenture + KfW 2012-08-24
Implandata–SEVERAL: investment, 201208 financing round Series A 2nd closing €1.6m Peppermint + EnjoyVenture + ERP Startfonds of KfW 2012-08-24
Univ Maryland–Bruker Corp: mass spectrometer, 201208 supply existent Bruker AmaZon X Ion Trap MS at MS Facility at School of Pharmacy 2012-08-24
Univ Maryland–Bruker Corp: mass spectrometer, 201208 supply existent Bruker Autoflex Speed MALDI TOF/TOF system at MS Facility at School of Pharmacy 2012-08-24
Univ Maryland–Thermo Fisher: mass spectrometer, 201208 supply existent Q-Exactive MS w Dionex UltiMate 3000 UHPLC at MS Facility at School of Pharmacy 2012-08-24
Univ Maryland–Thermo Fisher: mass spectrometer, 201208 supply existent TSQ Quantum Ultra w UltiMate 3000 UHPLC at MS Facility at School of Pharmacy 2012-08-24
Biochrom (DE)–Merck (DE): investment, 201208–201211 acquisition €na of Biochrom AG 2012-08-22
NeuroAllianz project–Germany (govt): grant, 201208– €15m BioPharma grant from BMBF 2012-08-22
Univ Rostock–Leco: mass spectrometer, 201208 supply Citius LC-HRT to Joint Mass Spectrometry Centre 2012-08-22
Univ Rostock–Leco: mass spectrometer, 201208 supply Pegasus GC-HRT to Joint Mass Spectrometry Centre 2012-08-22
Aperio–Danaher: investment, 201208 acquisition by Leica Biosystems 2012-08-21
Artes Biotechnology–Peschek Analytic Consulting: protein analysis, 201208– collab adding of PACs analytical services to Artes product portfolio 2012-08-21
BBG/Braun Group–Axa: investment, 201208 acquisition of Riemser Arzneimittel AG from Braun family + minority shareolders incl TVM Capital 2012-08-21
Penrith Corp–Siemens: investment, 201208– acquisition of substantially all assets by Siemens Healthcare ANNOUNCED 2012-08-21
Analis–Anagnostics: hybcell technology, 201208– distribution of Anagnostics’ products in Belgium + Luxembourg by Analis SA 2012-08-17
Analytik Jena–SEVERAL: credit, 201208– promissory note loan €30m replacing among other things existent €12m loan 2012-08-14
Avir Green Hills–NONE: investment, 201208–201308 bankruptcy 2012-08-12
Northwestern Univ–Keck Foundation: grant, 201208 grant $1m to Neil Kelleher for developm of new hybrid mass spectrometer w Thermo Fisher 2012-08-10
Thermo Fisher–Northwestern Univ: mass spectrometry, 201208– developm of new hybrid mass spectrometer with Prof Neil Kelleher 2012-08-10
Cempra–Curetis: Unyvero platform, 201208– collab r+d use of Unyvero system + Pneumonia test in P3 study of solithromycin 2012-08-09
EDMA–General Electric: in vitro diagnostics, 201208– membership PAA Laboratories becomes new member of EDMA 2012-08-09
Thermo Fisher–Martin Bauer Group: mass spectrometry, 201208 collab developm pesticide analysis mass spec method for herbal products PhytoLab GmbH 2012-08-09
Ecotech–Ionicon: mass spectrometer, 201208– distribution + support of Ioncion PTR-MS instruments by Ecotech Pty Ltd in Australia 2012-08-07
Ecotech–Ionicon: mass spectrometer, 201208– distribution + support of Ioncion PTR-MS instruments by Ecotech Pty Ltd in New Zealand 2012-08-07
Evonik–BRAIN: industrial biotechnology, 201208– collaboration €na developm of microorganisms to add properties to surfaces 2012-08-07
Aenova–BC Partners: investment, 201208 acquisition €500m of Aenova from majority shareholder Bridgepoint + two minority shareholders 2012-08-06
Novartis–Univ Pennsylvania: T-cell immunotherapy, 201208– collab excl ww RnD alliance to develop CAR cancer therapies 2012-08-06
Proteros–Bavaria (govt): investment, 201208 3rd financing round totalling €5m incl lead investor BayBG 2012-08-06
Proteros–BCNP Consultants: public relations, 201208 service existent by BCNP Consultants GmbH 2012-08-06
Proteros–SEVERAL: investment, 201208 3rd financing round €5m led by BayBG + incl two new investors 2012-08-06
Lonza–Univ Kyoto: stem cell technology, 201208– ww non-excl lisense to iPSC patent portfolio of iPS Acadamia Japan Inc 2012-08-02
Paragon Bioservices–Cevec: CAP technology, 201208– license to CAP + CAP-T cell expression systems for contract production of rec proteins + antibodies 2012-08-02
BlueGenics project–EU (govt): grant, 201208–201607 funding €6m out of total project cost of €8.45m 2012-08-01
AutoBio project–Germany (govt): grant, 201207–2015 BMBF grant for 3 years for programme with total volume of €3.7m 2012-07-31
Helicos–Qiagen: sequencing technology, 201207 license non-excl to 7 US patents for $1.6m from Intelligent Bio-Systems 2012-07-30
Prexton Therapeutics–Merck (DE): investment, 201207 seed financing €2.1m in spin-off of Merck Serono Geneva managed by Merck Serono Ventures 2012-07-30
General Electric–iBio: rec protein production, 201207– collab expansion €na global alliance iBioLaunch techn w CMB + ww marketing by GE Healthcare 2012-07-26
Rentschler–MHH: gene therapy vector system, 201207 license for commercialisation of vector system developed by Prof Baum et al 2012-07-25
Antisense Pharma–MC Services: public relations, 201207 service existent for Antisense Pharma GmbH 2012-07-24
Evonik–BioAmber: catalysts, 201207– collab long-term developm + manufacturing of catalysts to use bio-based succinic acid 2012-07-24
SuppreMol–Germany (govt): grant, 201207– BMBF grant €1.37m for early development of SM401 within m4 cluster initiative 2012-07-24
SuppreMol–Univ Regensburg: anti-IL-3 MAb, 201207– license developm for therapy + diagnosis of RA via Bayerische Patentallianz GmbH 2012-07-24
Boehringer–Funxional Therapeutics: anti-inflammatory drugs, 201207 acquisition €na global rights for FX125L + somatotaxin portfolio 2012-07-23
Fenwal–Fresenius: investment, 201207– acquisition €na of Fenwal Holdings Inc by Fresenius Kabi from TPG + Maverick Capital 2012-07-20
Univ North Carolina–Tecan: lab automation equipment, 201207 supply existent Freedom EVO 150 with LightCycler 480 RT PCR system at Dittmer Lab 2012-07-19
Advanced Technology Company–Curetis: Unyvero platform, 201207– distribution by ATC in all 6 GCC countries + Lebanon 2012-07-18
c-LEcta–Aquapharm: biocatalysts, 201207– collab developm + commercialisation of marine-derived biocatalysts part-supported by Eurostars grant 2012-07-18
Genetrix (ES)–Sygnis: investment, 201207–201212 acquisition of X-Pol by Sygnis via reverse merger w X-Pol holding 77.5% of Sygnis after closing 2012-07-18
Univ Luxembourg–Biobase: bioinformatics, 201207– supply + collab use of Genome Trax by LCSB to analyse NGS data in clinical diagnostics 2012-07-17
Qiagen–Genetrix (ES): DNA polymerase, 201207– license excl ww for Qualiphi polymerase from X-Pol Biotech 2012-07-16
Subitec–High-Tech Gründerfonds: investment, 201207 2nd financing round totalling €4.5m incl co-investor HTGF 2012-07-16
Subitec–SEVERAL: investment, 201207 2nd financing round €4.5m led by eCapital Entrepreneurial Partners AG 2012-07-16
Xtal Concepts–Hamburg (govt): investment, 201207 investment in Xtal Concepts GmbH by Innovationsstarter Fonds Hamburg 2012-07-16
Epivios–High-Tech Gründerfonds: investment, 201207 seed financing round from HTGF + LSI Pre-Seed-Fonds + TTHU + private investor 2012-07-11
Epivios–SEVERAL: investment, 201207 seed financing round from HTGF + LSI Pre-Seed-Fonds + TTHU + private investor 2012-07-11
Takeda–Genedata: bioinformatics, 201207 collab existent license to Genedata Expressionist for Mass Spectrometry s/w 2012-07-11
Takeda–Genedata: bioinformatics, 201207– collab expansion license to Genedata Expressionist for Genomic Profiling s/w 2012-07-11
Boehringer–Healthrageous: digital health management, 201207– collab digital diabetes self-management programme 2012-07-10
Helmholtz–Metabolon: mass spectrometry technology, 201207– collab Joint Metabolomics Laboratory at Helmholtz Zentrum München in Neuherberg 2012-07-10
Mologen–SEVERAL: investment, 201207 capital increase €22m gross proceeds 2,589,819 shares €8.5/share 2012-07-10
Bayer–Horizon Discovery: Genesis technology, 201207– collab €na development of pre-clinical cell line models for oncology research using Genesis 2012-07-09
Boehringer–Harvard Univ: drug research, 201207– collab funding of serveral translational research projects at Harvard by BI 2012-07-09
Genkyotex–SEVERAL: investment, 201207 financing round Series C extension of CHF25m=$26m from all Series C investors 2012-07-09
KWS Saat–Two Blades Foundation: TAL Code technology, 201207– non-excl commercial license €na to KWS Saat AG commercial use in certain crop plants 2012-07-09
Medicyte–Reinnervate: cell research technology, 201207– collab €na product integration of upcyte + Alevtex Scaffold technologies 2012-07-09
Celtic Therapeutics–Cancer Research UK: antibody-drug conjugates, 201207– collab €na developm ADCs to treat cancer by ADC Therapeutics + CRT 2012-07-06
Sinphar Pharmaceutical–Medigene: EndoTAG-1, 201207– collab excl co-developm + commercialisation by SynCore Biotechnology in Asia, AUS + NZ 2012-07-06
Merck (DE)–MDxHealth: molecular companion diagnostics, 201207– collab expansion €na ww developm + commerc PredictMDx for Glioblastoma w cilengitide 2012-07-05
4SC–SEVERAL: investment, 201207 capital increase up to 8.4m new shares €12.6m €1.5/share 2012-07-04
AgraQuest–Bayer: investment, 201207–201208 acquisition $425m + milestones by Bayer CropScience 2012-07-03
Euroimmun–Taylor Wessing: legal services, 201207 advisor to Euroimmun with regard to acquisition of GMK (BR) by Euroimmun 2012-07-03
Ferring–Albireo: elobixibat, 201207– license ww excl Japan + some Asian countries for developm + commercialisation 2012-07-03
GMK (BR)–Euroimmun: investment, 201207 acquisition 100% €na by Euroimmun Medizinische Labordiagnostik AG 2012-07-03
NZ Labs–Eurofins: investment, 201207 acquisition of New Zealand Laboratory Services Ltd by Eurofins 2012-07-02
Procognia–Scienion: print/spotting technology, 201207 supply use sciFlexarrayer to produce Multi Pad GlycoScope lectin microarray 2012-07-02
genXpress–Anagnostics: molecular diagnostics, 201207– distribution of pharmacogenetics products by genXpress in Austria 2012-07-01
Paion–Germany (govt): grant, 201207–201412 KMU-Innovativ BMBF grant €700k for developm of thrombomodulin-mutants 2012-07-01
Re-Liver project–EU (govt): grant, 201207c– FP7 grant €4.2m for developm of biomimetic bioartificial liver 2012-07-01
Corimmun–JnJ: investment, 201206 acquisition €100m + milestones durch Janssen-Cilag GmbH 2012-06-28
Anagnostics–Kompass: molecular diagnostics, 201206– collab + license for SepsiTest sample prep kit to develop hybcell Pathogens DNA 2012-06-27
Kreatech–Oridis: pharmacogenomics, 201206– collab developm + commercialisation of DNA-FISH assays for oncology 2012-06-26
Courtagen–Scienion: print/spotting technology, 201206 supply use sciFlexarrayer S11 to produce QDx BioChips for Avantra Q400 Biomarker Workstation 2012-06-25
Intelligent Bio-Systems–Qiagen: investment, 2012 acquisition €na 2012-06-25
Qiagen–SAP: bioinformatics, 201206– collab application of SAP HANA platform for analysis of sequencing data 2012-06-25
NEU² project–Epomedics: MS drug RnD, 201206– collab Epomedics GmbH becomes project member 2012-06-22
Zedira–R-Biopharm: investment, 201206 existing investor is R-Biopharm AG 2012-06-22
Peqlab–Eppendorf: thermal cycler, 201206– license covering gradient technology for thermal cyclers to Peqlab 2012-06-21
Bruker Corp–JMI Laboratories: MALDI Biotyper method, 201206– collab proteomic fingerprinting of fungi to expand MALDI Biotyper reference library 2012-06-18
Bruker Corp–United States (govt): MALDI Biotyper method, 201206– collab 1y w SBRL CDC analysis of bacterial isolates to expand reference library 2012-06-18
JMI Laboratories–Bruker Corp: mass spectrometer, 201206– supply JMI Labs to use MALDI Biotyper for proteomic fingerprinting of fungi 2012-06-18
NatLifE 2020 project–Germany (govt): grant, 201206– up to 9y funding from BMBF under Industrial Biotechnology Innovation Initiative 2012-06-18
United States (govt)–Bruker Corp: MALDI Biotyper method, 201206– collab 1y with SBRL at CDC each bacterial isolate analysed w Biotyper 2012-06-18
Vela–Eppendorf: automated liquid handling, 201206 collab joint developm of Sentosa SX system based on epMotion system for Vela Diagnostics 2012-06-18
Synthes–JnJ: investment, 201206 acquisition $19.7b with CHF55.65 in cash + 1.717 JnJ shares for each Synthes share 2012-06-14
Topsfield Medical–High-Tech Gründerfonds: investment, 201206 seed financing from HTGF 2012-06-14
Bayer–Abbott & Cobb: seeds, 201206 acquisition €na of watermelon + melon seed business by Bayer CropScience 2012-06-12
GSK–Basilea: alitretinoin, 201206 acquisition £146m upfront + milestones of excl ww Toctino rights incl distribution agreements by Stiefel 2012-06-11
Enzymicals–BBG/Braun Group: investment, 201206 acquisition of stake in Enzymicals AG by Braun Beteiligungs GmbH 2012-06-08
Enzymicals–BRAIN: investment, 201206 investment of an additional sum by BRAIN AG 2012-06-08
Tecan–Reinnervate: cell culture system, 201206– collab co-marketing Alvetex Scaffold for 3D cell culture on Freedom EVO liquid handling workstation 2012-06-07
next pagenext page 1 2 3 ... 37 38 39 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top